Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
October 6, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for March 6, 2008 Subscribe to this News Feed      
 

According to Erika Schwartz MD, New Antidepressant is the Wrong RX for Menopause

"The sensible and caring way to deal with the problems of menopause is to help women understand what happened to their bodies, how their diets affect the way they feel, how exercise improves the symptoms, how stress management helps them get the sleep they need, how supplementing their hormones with bioidentical hormones can help them get their lives back on track and enlighten the world with the wisdom they acquired along the way," says Erika Schwartz MD.

New York, NY (PRWEB) March 6, 2008 -- The news that Wyeth's new antidepressant Pristiq has won approval from the FDA should make us all depressed, says Erika Schwartz MD in her latest blog at www.drerika.com.

It is a particularly ominous development for women because Wyeth is also asking the FDA to approve the drug for the reduction of hot flashes in menopause, she writes.

The solution is not going to be found in giving them another drug to become dependent upon.
Pristiq will be the successor to Wyeth's Effexor XR, whose patent expires in two years. Sales of Effexor last year were $3.8 billion.

Dr. Erika says approval is proof the FDA is more anxious to protect profits of pharmaceutical companies than the wellbeing of the American public.

"The FDA whose mandate is to protect the public has spoken again," says Dr. Erika. "It has added yet another antidepressant to an already endless list of drugs that don't work."

Dr. Erika says the prospect of Pristiq being approved for menopause is truly disturbing. Treating menopause with anti-depressants is ineffective and dangerous, she says. If women are depressed during menopause it is because their hormones are depleted.

"The sensible and caring way to deal with the problems of menopause is to help women understand what happened to their bodies, how their diets affect the way they feel, how exercise improves the symptoms, how stress management helps them get the sleep they need, how supplementing their hormones with bioidentical hormones can help them get their lives back on track and enlighten the world with the wisdom they acquired along the way.

"The solution is not going to be found in giving them another drug to become dependent upon."

www.DrErika.com is dedicated to providing an independent, honest view on healthcare topics and issues from a position of devoted patient advocacy.

Its founder, Erika Schwartz, MD is an internationally-recognized patient advocate, practicing physician, expert in conventional and integrative medicine, author of four books and a frequent guest on TV and radio. DrErika.com doesn't tailor its stories to suit sponsors - it does not accept sponsors.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/WmV0YS1TcXVhLUNyYXMtSGFsZi1Ib3JyLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Gary Rosen
212-541-8641
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright